Clinical outcomes and prognostic factors in 4839 patients treated with external radiotherapy for stage T1-T2 prostate cancer
β Scribed by T.M. Pisansky; H.D. Thames; L.B. Levy; E.M. Horwitz; P.A. Kupelian; A.A. Martinez; J.M. Michalski; H.M. Sandler; W.U. Shipley; M.J. Zelefsky; A.L. Zietman; D.A. Kuban
- Book ID
- 108148463
- Publisher
- Elsevier Science
- Year
- 2004
- Tongue
- English
- Weight
- 68 KB
- Volume
- 60
- Category
- Article
- ISSN
- 0360-3016
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## BACKGROUND. This pilot randomized controlled trial (RCT) examined the clinical effects of 2 complementary (CAM) therapies, relaxation response therapy (RRT) and Reiki therapy, in men being treated with external beam radiotherapy (EBRx) for prostate cancer. ## METHODS. Study partic
## Abstract ## BACKGROUND The objective of the current study was to report biochemical recurrenceβfree survival (bRFS) rates among men with T1βT3 prostate carcinoma who were treated with externalβbeam radiotherapy (RT) at the Cleveland Clinic Foundation (Cleveland, OH). ## METHODS In total, 1352